High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: Findings from a population size estimation and respondent driven sampling survey

International Journal of Drug Policy

Volumn 22, Issue 4, 2011, Pages 252-258

  Johnston, Lisa ^a   Saumtally, Ahmed ^b   Corceal, Sewraz ^b   Mahadoo, Indrasen ^b   Oodally, Farida ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b AIDS Unit of the Mauritius Ministry of Health and Quality of Life   (Mauritius)

^c UNAIDS Office   (Mauritius)

Author keywords

HIV AIDS; Injection drug use; Mauritius; Population size estimations

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; DRUG ABUSE; FEMALE; HEALTH SURVEY; HEPATITIS B; HEPATITIS C; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INJECTION DRUG USE; MAJOR CLINICAL STUDY; MALE; MAURITIUS; POPULATION SIZE; PREVALENCE; PRIORITY JOURNAL; RESPONDENT DRIVEN SAMPLING; RISK FACTOR; SAMPLING; SEXUAL INTERCOURSE; SYPHILIS; UNSAFE SEX; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; CONDOMS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HEPATITIS B; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; MALE; MAURITIUS; MIDDLE AGED; NEEDLE SHARING; PREVALENCE; RISK FACTORS; SOCIAL ENVIRONMENT; SUBSTANCE ABUSE, INTRAVENOUS; SYPHILIS; YOUNG ADULT;

EID: 79960193012     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2011.05.007     Document Type: Article

References (21)

1. Abdool R., Sulliman F., Dhannoo M. The injecting drug use and HIV/AIDS nexus in the Republic of Mauritius. African Journal of Drug and Alcohol Studies 2006, 5(2):108-116.
2. Cleland C.M., Des Jarlais D.C., Perlis T.E., Stimson G., Poznyak V. HIV risk behaviors among female IDUs in developing and transitional countries. BMC Public Health 2007, 7:271. the WHO Phase II Drug Injection Collaborative Study Group.
3. Degenhardt, L., Larance, B., Mathers, B., Azim, T., Kamarulzaman, A., Mattick, R., et al. (2007). The benefits and risks of pharmaceutical opioids: Essential treatment and diverted medication. A global review of availability, extra-medical use, injection and the association with HIV. Sydney, Australia: National Drug and Alcohol Research Centre. Accessed 11.06.10. http://www.idurefgroup.unsw.edu.au/IDURGWeb.nsf/resources/thematic+papers/$file/Pharmaceutical+opioid+injection.pdf.
4. Dewing S., Pluddemann A., Myers B., Parry C. Review of injection drug use in six African countries: Egypt, Kenya, Mauritius, Nigeria, South Africa and Tanzania. Drugs Education and Prevention Policy 2006, 13(2):121-137.
5. Heckathorn D. Respondent driven sampling II: Deriving valid population estimates from Chain-referral samples of hidden populations. Social Problems 2002, 49(1):11-34.
6. Heckathorn D. Respondent driven sampling: A new approach to the study of hidden populations. Social Problems 1997, 44(2):174-199.
7. Heckathorn D. Extensions of Respondent-Driven Sampling: Analyzing Continuous Variables and Controlling for Differential Recruitment. Sociological Methodology 2007, 23(1):151-207.
8. Malekinejad M., Johnston L.G., Kendall C., Kerr L., Rifkin M., Rutherford G. Using respondent-driven sampling methodology for HIV biological and behavioral surveillance in international settings: a systematic review. AIDS and Behavior 2008, 12(suppl 1):105-130.
9. Mathers B.M., Degenhardt L., Adam P., Toskin I., Nashkhoev M., Lyerla R., et al. Estimating the level of HIV prevention coverage, knowledge and protective behavior among injecting drug users: What does the 2008 UNGASS reporting round tell us?. JAIDS 2009, 52:S132-S142.
10. Mauritius Ministry of Health and Quality of Life Mauritius National HIV/AIDS Strategic Framework 2001-05 2001, Ministry of Health, Port-Louis, Mauritius.
11. Mauritius Ministry of Health and Quality of Life Mauritius National HIV/AIDS Strategic Framework 2007-2011 2007, Ministry of Health, Port-Louis, Mauritius.
12. National Agency for the Treatment and Rehabilitation of Substance Abusers Rapid Situational Assessment-2004 2004, Port Louis, Mauritius.
13. Republic of Mauritius. (2010). Country progress report: Declaration of commitment of the United Nations General Assembly Special Session (UNGASS) on HIV/AIDS. Accessed August 21. http://www.unaidsrstesa.org/files/u1/mauritius_2010_country_progress_report_en.pdf.
14. Salganik M.J., Heckathorn D.D. Sampling and estimation in hidden populations using Respondent Driven Sampling. Sociological Methodology 2004, 3:193-239.
15. Schwarz T.F., Dobler G., Gilch S., Jäger G. Hepatitis C and arboviral antibodies in the island populations of Mauritius and Rodrigues. Journal of Medical Virology 1994, 44(4):379-383.
16. UNAIDS, (2009). Mauritius 2010 Country Progress Report. Geneva, Switzerland. Accessed 23.04.10. http://data.unaids.org/pub/Report/2010/mauritius_2010_country_progress_report_en.pdf.
17. UNAIDS, (2008). Mauritius 2008 Country Progress Report. Geneva, Switzerland. Accessed 27.12.09. http://data.unaids.org/pub/Report/2008/mauritius_2008_country_progress_report_en.pdf.
18. UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance. (2010). Estimating the size of populations most at risk to HIV. Geneva, Switzerland. Accessed 1.03.11. http://globalhealthsciences.ucsf.edu/PPHG/surveillance/surv_modules.html.
19. UNODC. (2006). HIV/AIDS prevention and care for female injecting drug users. Austria. Accessed 5.06.10. http://www.unodc.org/pdf/HIV-AIDS_femaleIDUs_Aug06.pdf.
20. UNODC. (2009). World drug report 2009. Geneva, Switzerland. Accessed 11.06.10. http://www.unodc.org/unodc/en/data-and-analysis/WDR-2009.html.
21. World Health Organization. (2008). Preliminary results rapid assessment of HIV/STI serological and behavioral surveillance system in Mauritius. Geneva, Switzerland.